Microfluidic Electrophoresis Platform for Analysis of Pancreatic Cancer Exosomes

dc.contributor.advisorKalluri, Raghu
dc.contributor.advisorKono, Junichiro
dc.creatorKapoor, Kshipra
dc.date.accessioned2019-11-08T17:31:31Z
dc.date.available2020-12-01T06:01:10Z
dc.date.created2019-12
dc.date.issued2019-11-07
dc.date.submittedDecember 2019
dc.date.updated2019-11-08T17:31:32Z
dc.description.abstractPancreatic cancer (PaCa) has a dismal prognosis, due to extremely late diagnosis, aggressive local metastasis, and limited treatment options. Thus, there is an urgent need for early detection methods for PaCa to increase the likelihood of treatment success. Liquid biopsy (marker detection in biofluids) is the only feasible approach for early diagnosis, as the biopsy of pancreatic tissue is not practical in patients lacking overt symptoms, and only minimally invasive methods can be used for sample collection. Recent studies demonstrate the use of exosomes as a means to improve the sensitivity of liquid biopsies. Most of the ongoing work utilizes stand-alone immunoaffinity-based capture of disease-associated exosomes in body fluids. The drawback of this approach is the heterogeneity of the exosome population, as the protein marker(s) of interest are typically expressed only by specific tumor subtypes, and the use of a single marker may result in false-negative or false-positive results or limit the enrichment capacity. In this work, we develop the novel principle of exosome fractionation based on their charge. The feasibility of the approach is based on our findings, which show a strong correlation between the negative charge of the exosomes and PaCa aggressiveness. Further analysis identified the enhanced incorporation of phosphatidylserine and DNA fragments in the outer leaflet of exosomal membranes, as the molecular cause of the highly anionic nature of cancer-derived exosomes. The use of a label-free separation approach allows us to collect intact exosomes and enables a broader range of downstream molecular analyses, unavailable in the permanent modifications by the tagging molecules on exosomes incurred by immunoaffinity techniques. Hence allowing for a multiplexed detection of biophysical and biomolecular properties of exosomes. We have designed and developed a prototype microfluidic platform that uses electrophoresis principles to isolate highly anionic exosomes, which correspond to the cancer-derived exosome population in patient serum. Further development of such a device for the detection of highly anionic exosomes in patient sera, would yield a much-needed tool for early PaCa diagnosis.
dc.embargo.terms2020-12-01
dc.format.mimetypeapplication/pdf
dc.identifier.citationKapoor, Kshipra. "Microfluidic Electrophoresis Platform for Analysis of Pancreatic Cancer Exosomes." (2019) Master’s Thesis, Rice University. <a href="https://hdl.handle.net/1911/107626">https://hdl.handle.net/1911/107626</a>.
dc.identifier.urihttps://hdl.handle.net/1911/107626
dc.language.isoeng
dc.rightsCopyright is held by the author, unless otherwise indicated. Permission to reuse, publish, or reproduce the work beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder.
dc.subjectPancreatic cancer
dc.subjectExosomes
dc.subjectEarly detection
dc.subjectMicrofluidics
dc.subjectElectrophoresis
dc.titleMicrofluidic Electrophoresis Platform for Analysis of Pancreatic Cancer Exosomes
dc.typeThesis
dc.type.materialText
thesis.degree.departmentElectrical and Computer Engineering
thesis.degree.disciplineEngineering
thesis.degree.grantorRice University
thesis.degree.levelMasters
thesis.degree.nameMaster of Science
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
KAPOOR-DOCUMENT-2019.pdf
Size:
22.73 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
PROQUEST_LICENSE.txt
Size:
5.84 KB
Format:
Plain Text
Description:
No Thumbnail Available
Name:
LICENSE.txt
Size:
2.61 KB
Format:
Plain Text
Description: